FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2106578889> ?p ?o ?g. }

• W2106578889 endingPage "5" @default.
• W2106578889 startingPage "5" @default.
• W2106578889 abstract "Purpose: IgA1 aberrant O-glycosylation is one of the main pathogenetic features of IgA nephropathy (IgAN). This study attempted to determine the role of C1GALT1C1 in aberrant IgA1 O-glycosylation induced by lipopolysaccharide (LPS) and identify potential therapeutic targets in IgAN. Methods: Lymphocytes isolated from 22 patients with IgAN and 17 normal controls were cultured for 3 to 7 days with or without LPS and 5-azacytidine (5-AZA). Expression levels of C1GALT1C1 mRNA and protein were measured by real-time PCR and Western blot analysis, respectively. Concentration of IgA1 and level of O-glycosylation were determined by ELISA and Vicia villosa (VV) lectin-binding assay. Correlation analysis was performed between the expression of C1GALT1C1 protein and IgA1 O-glycosylation. Results: Lymphocytes from patients with IgAN secreted more IgA1 than that from normal controls after LPS stimulation (P=0.26, 0.002 and 0.005 on the 3rd, 5th and 7th day, respectively) which could be inhibited by 5-AZA (P=0.001, 0.025 and 0.001 on the 3rd, 5th and 7th day, respectively). Moreover, LPS stimulation could obviously inhibit C1GALT1C1 expression in patients with IgAN (decreased by 71%, 82% and 92% on the 3rd, 5th and 7th day, respectively; P < 0.001), and cause a significant decrease of IgA1 O-glycosylation compared with normal controls (P=0.004, 0.003 and 0.03 on the 3rd, 5th and 7th day, respectively). When 5-AZA was added, the level of C1GALT1C1 expression increased dramatically (1.98, 5.53 and 8.97 times on the 3rd, 5th and 7th day, respectively; P < 0.001) along with an increase of IgA1 O-glycosylation (P=0.295, 0.09 and 0.003 on the 3rd, 5th and 7th day, respectively). However, normal controls showed no significant change in C1GALT1C1 expression and IgA1 O-glycosylation after LPS stimulation (P > 0.05). Conclusion: LPS induced IgA1 aberrant O-glycosylation and suppressed C1GALT1C1 expression in patients with IgAN. Upregulation of C1GALT1C1 expression by 5-AZA could reverse the IgA1 aberrant O-glycosylation. These results suggest that C1GALT1C1 may play a key role in the regulation of IgA1 O-glycosylation." @default.
• W2106578889 created "2016-06-24" @default.
• W2106578889 creator A5021170475 @default.
• W2106578889 creator A5045425075 @default.
• W2106578889 creator A5076600969 @default.
• W2106578889 creator A5084123261 @default.
• W2106578889 creator A5089090788 @default.
• W2106578889 creator A5089249014 @default.
• W2106578889 date "2010-02-01" @default.
• W2106578889 modified "2023-09-25" @default.
• W2106578889 title "The role of C1GALT1C1 in lipopolysaccharide-induced IgA1 aberrant O-glycosylation in IgA nephropathy" @default.
• W2106578889 cites W1919996070 @default.
• W2106578889 cites W1971076121 @default.
• W2106578889 cites W1975329297 @default.
• W2106578889 cites W1976374979 @default.
• W2106578889 cites W1995181053 @default.
• W2106578889 cites W2004078197 @default.
• W2106578889 cites W2014260834 @default.
• W2106578889 cites W2040149948 @default.
• W2106578889 cites W2041663568 @default.
• W2106578889 cites W2049499509 @default.
• W2106578889 cites W2059977353 @default.
• W2106578889 cites W2083379162 @default.
• W2106578889 cites W2085219369 @default.
• W2106578889 cites W2106285921 @default.
• W2106578889 cites W2108206148 @default.
• W2106578889 cites W2108244474 @default.
• W2106578889 cites W2113950481 @default.
• W2106578889 cites W2119832679 @default.
• W2106578889 cites W2135239485 @default.
• W2106578889 cites W2140020627 @default.
• W2106578889 cites W2156501795 @default.
• W2106578889 doi "https://doi.org/10.25011/cim.v33i1.11832" @default.
• W2106578889 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20144270" @default.
• W2106578889 hasPublicationYear "2010" @default.
• W2106578889 type Work @default.
• W2106578889 sameAs 2106578889 @default.
• W2106578889 citedByCount "14" @default.
• W2106578889 countsByYear W21065788892012 @default.
• W2106578889 countsByYear W21065788892013 @default.
• W2106578889 countsByYear W21065788892014 @default.
• W2106578889 countsByYear W21065788892015 @default.
• W2106578889 countsByYear W21065788892016 @default.
• W2106578889 countsByYear W21065788892018 @default.
• W2106578889 countsByYear W21065788892019 @default.
• W2106578889 countsByYear W21065788892020 @default.
• W2106578889 countsByYear W21065788892021 @default.
• W2106578889 crossrefType "journal-article" @default.
• W2106578889 hasAuthorship W2106578889A5021170475 @default.
• W2106578889 hasAuthorship W2106578889A5045425075 @default.
• W2106578889 hasAuthorship W2106578889A5076600969 @default.
• W2106578889 hasAuthorship W2106578889A5084123261 @default.
• W2106578889 hasAuthorship W2106578889A5089090788 @default.
• W2106578889 hasAuthorship W2106578889A5089249014 @default.
• W2106578889 hasBestOaLocation W21065788891 @default.
• W2106578889 hasConcept C104317684 @default.
• W2106578889 hasConcept C105580179 @default.
• W2106578889 hasConcept C126322002 @default.
• W2106578889 hasConcept C134018914 @default.
• W2106578889 hasConcept C153911025 @default.
• W2106578889 hasConcept C185592680 @default.
• W2106578889 hasConcept C203014093 @default.
• W2106578889 hasConcept C24998067 @default.
• W2106578889 hasConcept C2776415932 @default.
• W2106578889 hasConcept C2777313579 @default.
• W2106578889 hasConcept C2778754761 @default.
• W2106578889 hasConcept C2781184683 @default.
• W2106578889 hasConcept C55493867 @default.
• W2106578889 hasConcept C555293320 @default.
• W2106578889 hasConcept C71924100 @default.
• W2106578889 hasConcept C86803240 @default.
• W2106578889 hasConceptScore W2106578889C104317684 @default.
• W2106578889 hasConceptScore W2106578889C105580179 @default.
• W2106578889 hasConceptScore W2106578889C126322002 @default.
• W2106578889 hasConceptScore W2106578889C134018914 @default.
• W2106578889 hasConceptScore W2106578889C153911025 @default.
• W2106578889 hasConceptScore W2106578889C185592680 @default.
• W2106578889 hasConceptScore W2106578889C203014093 @default.
• W2106578889 hasConceptScore W2106578889C24998067 @default.
• W2106578889 hasConceptScore W2106578889C2776415932 @default.
• W2106578889 hasConceptScore W2106578889C2777313579 @default.
• W2106578889 hasConceptScore W2106578889C2778754761 @default.
• W2106578889 hasConceptScore W2106578889C2781184683 @default.
• W2106578889 hasConceptScore W2106578889C55493867 @default.
• W2106578889 hasConceptScore W2106578889C555293320 @default.
• W2106578889 hasConceptScore W2106578889C71924100 @default.
• W2106578889 hasConceptScore W2106578889C86803240 @default.
• W2106578889 hasIssue "1" @default.
• W2106578889 hasLocation W21065788891 @default.
• W2106578889 hasLocation W21065788892 @default.
• W2106578889 hasLocation W21065788893 @default.
• W2106578889 hasOpenAccess W2106578889 @default.
• W2106578889 hasPrimaryLocation W21065788891 @default.
• W2106578889 hasRelatedWork W1980194808 @default.
• W2106578889 hasRelatedWork W1984619393 @default.
• W2106578889 hasRelatedWork W2034768996 @default.
• W2106578889 hasRelatedWork W2042786471 @default.
• W2106578889 hasRelatedWork W2046401998 @default.

• next